Robina Private Hospital is proud to introduce Anti-Amyloid Infusion Therapy — a groundbreaking treatment for patients living with early Alzheimer’s disease. This innovative therapy, offered at our New & Emerging Therapies (NET) Clinic, represents a major step forward in dementia care, offering hope to families navigating the challenges of memory loss.
Anti-Amyloid Infusion Therapy uses disease-modifying medications — Donanemab and Lecanemab — to target beta-amyloid plaques in the brain. These plaques are a hallmark of Alzheimer’s disease and contribute to cognitive decline. By reducing amyloid buildup, these therapies can slow the progression of symptoms, helping patients maintain independence for longer.
Unlike traditional treatments that only manage symptoms, this is the first class of therapies designed to modify the disease process. For many patients, this means more time for meaningful moments with loved ones.
“It’s not about reversing the disease process as much as delaying the decline. People will remain well for a lot longer.”
— Dr Penny King, Robina Private Hospital
Anti-Amyloid Infusion Therapy is suitable for:
Early identification is critical. Patients benefit most when treatment begins in the early stages of Alzheimer’s disease.
The infusion process is similar to an iron infusion and typically occurs fortnightly or monthly, depending on your treatment plan.
General Practitioners play a vital role in:
A special thank you to Channel 9 Gold Coast for shining a spotlight on this important treatment and helping raise awareness for families navigating dementia care.
We offer more than infusion therapy. Our approach includes:
If you or someone you care for may benefit from Anti-Amyloid Infusion Therapy: